Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heliox in Infants With RSV Acute Bronchiolitis
NCT03171142Phase 3Completed
- Start
- May 2015
- Primary completion
- Aug 2016
- Modality
- GAS (Genetic analysis systems)
01
Overview
Phase 3, randomised trial of heliox in acute bronchiolitis (2 arms). Primary endpoint: Improvement in oxygenation at 24 hours. Started May 2015; status: completed.
02
Drugs
heliox
03
Conditions
acute bronchiolitis
Beyond the preview
Go deeper on NCT03171142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03171142.